BioNTech (NASDAQ: BNTX), the German drugmaker, has agreed to acquire Chinese biotech company Biotheus to support its oncology strategy and
1 year ago
Alcon (NYSE: ALC), the eye-care group, cut its 2024 forecasts and missed market expectations for third-quarter sales on Tuesday evening,
On Tuesday, Novavax (NASDAQ: NVAX) cut its annual revenue forecast, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing
Drugmaker AstraZeneca (LON: AZN) lifted its annual sales and profit forecast for the second time this year on Tuesday, helped
U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk’s (NYSE: NVO) highly in-demand drugs for diabetes
Shares in Evotec (NASDAQ: EVO) soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake
MADRID – On Thursday, Grifols (NASDAQ: GRFS), the Spanish drugmaker, said it was on track to meet its targets for
Oaktree Capital Management, the investment fund, has urged British drugmaker Indivior (NASDAQ: INDV) to cooperate with the fund in refreshing
On Wednesday, Qiagen (NYSE: QGEN) reported a rise in third-quarter revenue, owing to strong sales of its diagnostic devices. The
Gilead Sciences (NASDAQ: GILD) reported third-quarter financial results that handily beat Wall Street expectations on Wednesday as sales climbed 7%,
LONDON – Novo Nordisk’s (NYSE: NVO) sales growth next year could be in the high teens in percentage terms, Chief
JERUSALEM – Teva Pharmaceutical Industries (NYSE: TEVA) expects to work productively with the incoming Trump administration in the United States,
